PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-70.17%
Both yoy net incomes decline, with VET at -17.40%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
-6.47%
Negative yoy D&A while VET is 13.22%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.36%
Negative yoy working capital usage while VET is 231.78%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-20.36%
Negative yoy usage while VET is 231.78%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
150.06%
Some yoy increase while VET is negative at -229.07%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-2.22%
Negative yoy CFO while VET is 38.76%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
7.86%
Lower CapEx growth vs. VET's 46.41%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
103.40%
Acquisition growth of 103.40% while VET is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
1558.05%
Growth well above VET's 202.67%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
29.17%
Investing outflow well above VET's 33.89%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-59.85%
Both yoy lines negative, with VET at -160.13%. Martin Whitman suspects an environment or preference for internal financing over new equity in the niche.
No Data
No Data available this quarter, please select a different quarter.